TMCO7 Polyklonaler Antikörper

TMCO7 Polyklonal Antikörper für WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 32692-1-AP

Synonyme

KIAA1746, TANGO6, Transmembrane and coiled-coil domain-containing protein 7, Transport and Golgi organization protein 6 homolog

---

• 

  WB analysis using 32692-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 32692-1-AP (TMCO7 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 32692-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 32692-1-AP (TMCO7 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: K-562-Zellen, U2OS-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:1000-1:8000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

32692-1-AP bindet in WB, ELISA TMCO7 und zeigt Reaktivität mit human

• Getestete Reaktivität: human
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: TMCO7 fusion protein Ag38358
• Vollständiger Name: transmembrane and coiled-coil domains 7
• Berechnetes Molekulargewicht: 1094 aa, 120 kDa
• Beobachtetes Molekulargewicht: 120 kDa
• GenBank-Zugangsnummer: BC015617
• Gene symbol: TMCO7
• Gene ID (NCBI): 79613
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS with 0.02% sodium azide and 50% glycerol
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TMCO7, also known as transmembrane and coiled-coil domain 7 or TANGO6. MCO7 is predicted to play a role in protein secretion and is considered an integral component of the membrane. TMCO7 has been implicated in leukemia, with ongoing research focusing on validating its role using in vivo leukemic mouse models and protein localization studies. It is being explored as a potential therapeutic target for acute myeloid leukemia (AML).